Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

February 28, 2009

Study Completion Date

December 31, 2009

Conditions
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Interventions
DRUG

gemcitabine, oxaliplatin, capecitabine

gemcitabine day 1 and 8, oxaliplatin day 1, capecitabine days 1-14, q3weeks

Trial Locations (8)

Unknown

Cantonal Hospital Bruderholz, Bruderholz

Cantonal Hospital Liestal, Liestal

St. Clara Hospital, Basel

University Hospital Basel, Basel

Cantonal Hospital Lucerne, Lucerne

City Hospital Triemli, Zurich

Oncocenter Hirslanden, Zurich

University Hospital, Zurich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

collaborator

Swiss Cancer League

OTHER

collaborator

Roche Pharma AG

INDUSTRY

collaborator

Sanofi

INDUSTRY

lead

University Hospital, Basel, Switzerland

OTHER